TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,584,000 | +0.6% | 2,400,000 | 0.0% | 0.09% | +3.4% |
| Q1 2017 | $2,568,000 | +184.1% | 2,400,000 | +272.1% | 0.09% | +155.9% |
| Q2 2015 | $904,000 | -55.0% | 645,000 | -52.2% | 0.03% | -55.3% |
| Q1 2015 | $2,009,000 | +22.6% | 1,350,000 | +12.5% | 0.08% | 0.0% |
| Q4 2014 | $1,639,000 | -74.0% | 1,200,000 | -75.5% | 0.08% | -70.1% |
| Q3 2014 | $6,297,000 | -3.3% | 4,900,000 | -3.0% | 0.25% | -1.9% |
| Q2 2014 | $6,515,000 | +9.1% | 5,050,000 | +7.4% | 0.26% | +4.4% |
| Q1 2014 | $5,970,000 | +107.2% | 4,700,000 | +74.1% | 0.25% | +105.0% |
| Q4 2013 | $2,881,000 | – | 2,700,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 91,833,000 | $98,950,000 | 5.16% |
| Ferox Capital Management LP | 5,390,000 | $5,796,000 | 2.37% |
| INCOME RESEARCH & MANAGEMENT | 7,472,000 | $8,014,000 | 2.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 14,535 | $8,641,000 | 1.47% |
| Lombard Odier Asset Management (Europe) Ltd | 21,660,000 | $23,433,000 | 1.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,864,000 | $12,783,000 | 1.15% |
| MACKAY SHIELDS LLC | 18,887,000 | $20,335,000 | 0.86% |
| AEGON USA Investment Management, LLC | 4,000,000 | $4,290,000 | 0.84% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,751,000 | $35,196,000 | 0.67% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,067,000 | $6,522,000 | 0.24% |